[ORGANIZATION]
Piramal Pharma Solutions
Featured in 2 tracked stories · first seen
Situations
Piramal Pharma business expansion and growth
2 clusters · 7 sources · last updated
Latest: Piramal Pharma acquires controlling stake in Yapan Bio
Piramal Pharma Limited reported strong financial performance for the first quarter of fiscal year 2027, noting a 17% increase in revenue to ₹2,270 crore and a 72% rise in EBITDA to ₹285 crore. Chairperson Nandini Piramal
Deep Polymers Limited financial performance
2 clusters · 4 sources · last updated
Latest: Deep Polymers Limited reports 32% rise in Q1 PAT
Deep Polymers Limited reported a 32% increase in Profit After Tax (PAT) for the first quarter of fiscal year 2027, reaching ₹1.90 crore. The company’s revenue from operations grew 20% year-on-year to ₹30.07 crore. To su